Tetravalent neutralizing antibody response against four dengue serotypes by a single chimeric dengue envelope antigen

被引:53
|
作者
Apt, D
Raviprakash, K
Brinkman, A
Semyonov, A
Yang, SM
Skinner, C
Diehl, L
Lyons, R
Porter, K
Punnonen, J
机构
[1] Maxygen Inc, Human Therapeut, Redwood City, CA 94063 USA
[2] USN, Med Res Ctr, Viral Dis Dept, Silver Spring, MD 20910 USA
[3] Univ New Mexico, Hlth Sci Ctr, Dept Internal Med, Albuquerque, NM 87131 USA
关键词
dengue virus; antigen; tetravalent; multivalent antigen; DNA shuffling; cross-neutralizing antibodies;
D O I
10.1016/j.vaccine.2005.07.100
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We employed DNA shuffling and screening technologies to develop a single recombinant dengue envelope (E) antigen capable of inducing neutralizing antibodies against all four antigenically distinct dengue serotypes. By DNA shuffling of codon-optimized dengue 1-4 E genes, we created a panel of novel chimeric clones expressing C-terminal truncated E antigens that combined epitopes from all four dengue serotypes. DNA vaccines encoding these novel chimeras induced multivalent T cell and neutralizing antibody responses against all four dengue serotypes in mice. By contrast, a mixture of four unshuffled, parental DNA vaccines failed to produce tetravalent neutralizing antibodies in mice. length neutralizing antibody titers for some of these antigens could be further improved by extending the sequences to express full membrane and envelope proteins. The chimeric antigens also protected mice against a lethal dengue-2 virus challenge. These data demonstrate that DNA shuffling and associated screening can lead to the selection of multi-epitope antigens against closely related dengue virus serotypes and suggest a broad utility for these technologies in optimizing vaccine antigens. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:335 / 344
页数:10
相关论文
共 50 条
  • [21] Tetravalent dengue vaccine based on complex adenovirus vectors protects rhesus monkeys against challenge from all four dengue serotypes
    Raviprakash, Kanakatte
    Dong, John
    Ewing, Dan
    Block, Karla
    Wang, Danher
    Holman, David
    Chen, Lan
    Woraratanadharm, Jan
    Porter, Kevin
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2007, 77 (05): : 99 - 99
  • [22] Neutralizing antibody correlates of sequence specific dengue disease in a tetravalent dengue vaccine efficacy trial in Asia
    Qi, Li
    Sun, Yanqing
    Juraska, Michal
    Moodie, Zoe
    Magaret, Craig A.
    Heng, Fei
    Carpp, Lindsay N.
    Gilbert, Peter B.
    [J]. VACCINE, 2022, 40 (41) : 5912 - 5923
  • [23] Development of a novel DNA SynCon™ tetravalent dengue vaccine that elicits immune responses against four serotypes
    Ramanathan, Mathura P.
    Kuo, Yuan-Chia
    Selling, Bernard H.
    Li, Qianjun
    Sardesai, Niranjan Y.
    Kim, J. Joseph
    Weiner, David B.
    [J]. VACCINE, 2009, 27 (46) : 6444 - 6453
  • [24] DISSECTING THE SPECIFICITY OF THE NEUTRALIZING ANTIBODY RESPONSE TO A LIVE ATTENUATED TETRAVALENT DENGUE VACCINE (TDV) CANDIDATE
    Henein, Sandra
    Swanstrom, Jesica
    Widman, Douglas G.
    Stinchcomb, Dan T.
    Dean, Hansi
    Osorio, Jorge E.
    Partidos, Charalambos D.
    Baric, Ralph S.
    de Silva, Aravinda
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2015, 93 (04): : 165 - 165
  • [25] Delineating the serotype-specific neutralizing antibody response to a live attenuated tetravalent dengue vaccine
    Gromowski, Gregory D.
    Henein, Sandra
    Kannadka, Chandrika B.
    Barvir, David A.
    Thomas, Stephen J.
    de Silva, Aravinda M.
    Jarman, Richard G.
    [J]. VACCINE, 2018, 36 (18) : 2403 - 2410
  • [26] Optimization of Flow-Cytometry Based Assay for Measuring Neutralizing Antibody Responses against Each of the Four Dengue Virus Serotypes
    Sharma, Pragati
    Nayak, Kaustuv
    Reddy, Elluri Seetharami
    Farooqi, Humaira
    Murali-Krishna, Kaja
    Chandele, Anmol
    [J]. VACCINES, 2021, 9 (11)
  • [27] Publisher Correction: A potent neutralizing antibody with therapeutic potential against all four serotypes of dengue virus (vol 2, 2017)
    Xu, Meihui
    Zuest, Roland
    Velumani, Sumathy
    Tukijan, Farhana
    Toh, Ying Xiu
    Appanna, Ramapraba
    Tan, Ern Yu
    Cerny, Daniela
    MacAry, Paul
    Wang, Cheng-I
    Fink, Katja
    [J]. NPJ VACCINES, 2018, 3
  • [28] A tetravalent dengue vaccine based on a complex adenovirus vector provides significant protection in rhesus monkeys against all four serotypes of dengue virus
    Raviprakash, Kanakatte
    Wang, Danher
    Ewing, Dan
    Holman, David H.
    Block, Karla
    Woraratanadharm, Jan
    Chen, Lan
    Hayes, Curtis
    Dong, John Y.
    Porter, Kevin
    [J]. JOURNAL OF VIROLOGY, 2008, 82 (14) : 6927 - 6934
  • [29] Direct and indirect interactions in the recognition between a cross- neutralizing antibody and the four serotypes of dengue virus
    Lisova, Olesia
    Belkadi, Laurent
    Bedouelle, Hugues
    [J]. JOURNAL OF MOLECULAR RECOGNITION, 2014, 27 (04) : 205 - 214
  • [30] Evaluation of envelope domain III-based single chimeric tetravalent antigen and monovalent antigen mixtures for the detection of anti-dengue antibodies in human sera
    Gaurav Batra
    Satish K Nemani
    Poornima Tyagi
    Sathyamangalam Swaminathan
    Navin Khanna
    [J]. BMC Infectious Diseases, 11